Novel long-acting ropeginterferon alfa-2b: Pharmacokinetics, pharmacodynamics and safety in a phase I clinical trial

  • Yi Wen Huang
  • , Albert Qin
  • , Jane Fang
  • , Ting Fang Wang
  • , Chung Wei Tsai
  • , Ko Chung Lin
  • , Ching Leou Teng
  • , Richard Larouche

Research output: Contribution to journal › Article › peer-review

27 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Novel long-acting ropeginterferon alfa-2b: Pharmacokinetics, pharmacodynamics and safety in a phase I clinical trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology